Interestingly, >80% of the homologous genes were found to be involved either in signal transduction or cell-cell interaction pathways whereas remaining ~20% were implicated with several diseases reported in the human.
Notch signaling defines a conserved, pleiotropic cell-interaction pathway that controls cell fates and consequently many differentiation, proliferation and apoptotic events throughout development [1] [3].
Experimental results indicate that the CNTs/SF polymer surface may be able to activate several cell-material interaction pathways and promote cell adhesion.
It is evident, therefore, that substantial redundancies exist across the signalling and cell-matrix interaction pathways that are associated with hESC adhesion and self-renewal.
The injury-induced activation of growth-promoting and cell-cell/ECM interaction pathways in aged WT mice was evident even after a histologically confirmed full closure of the wound (Day 21), indicating an ongoing tissue remodeling.
The first network connected the five genes that were up-regulated in DCIS with nine additional genes showing an enrichment of genes belonging to the Cell-To-Cell Signalling and Interaction pathway.
Figure 6 illustrates such a network that centers largely on such genes as THBS1, PITX2, ID1, RBL1 and INHBA involved in TGF-beta signaling pathways, linking cell cycle, cell communication and cytokine-cytokine receptor interaction pathways together.
Decreased membrane flexibility may compromise the effect of RBC on microcirculatory flow and participates in increasing red cell-endothelial cell interaction, with activation of inflammatory pathways.
Besides the 'Cell Cycle' pathway, the 'ECM-receptor interaction' pathway interacts with the 'Cell adhesion molecules (CAMs)'.
Further research is required to mechanistically confirm this model and to elucidate the interaction pathways between leukemia cells and cells of the tumor microenvironment.
Cluster maps of DNA replication, mismatch repair, cell cycle, p53 signaling, Notch signaling, small cell lung cancer and ECM-receptor interaction pathways are shown in Fig. 3b.
